journal
Journals Journal of Antimicrobial Chemo...

Journal of Antimicrobial Chemotherapy

https://read.qxmd.com/read/37225672/correction-to-simultaneous-and-divergent-evolution-of-resistance-to-cephalosporin-%C3%AE-lactamase-inhibitor-combinations-and-imipenem-relebactam-following-ceftazidime-avibactam-treatment-of-mdr-pseudomonas-aeruginosa-infections
#21
https://read.qxmd.com/read/37221129/correction-to-comparative-effectiveness-of-%C3%AE-lactams-for-empirical-treatment-of-methicillin-susceptible-staphylococcus-aureus-bacteraemia-a-prospective-cohort-study
#22
(no author information available yet)
No abstract text is available yet for this article.
May 23, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37220765/comment-on-long-term-outcome-of-dolutegravir-containing-regimens-according-to-sex-data-from-the-icona-study
#23
EDITORIAL
Arturo Ciccullo, Gianmaria Baldin, Gaetana Sterrantino, Giordano Madeddu, Gabriella D'ettorre, Cristina Mussini, Simona Di Giambenedetto
No abstract text is available yet for this article.
May 23, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37220755/antibiotic-prescription-patterns-during-last-days-of-hospitalized-patients-with-advanced-cancer-the-role-of-palliative-care-consultation
#24
JOURNAL ARTICLE
Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
OBJECTIVES: Issues regarding antibiotic use in end-of-life patients with advanced cancer present a challenging ethical dilemma in academic referral centres. This study aimed to investigate the role of palliative care consultation on antibiotic prescription patterns among hospitalized patients with advanced cancer during their last days of life. METHODS: This retrospective cohort study included adult patients with metastatic solid cancer admitted to a tertiary referral hospital for at least 4 days and subsequently died and who were given antibiotics 4 days before death between January 2018 and December 2021...
May 23, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37220664/invasive-candidiasis-current-clinical-challenges-and-unmet-needs-in-adult-populations
#25
JOURNAL ARTICLE
Alex Soriano, Patrick M Honore, Pedro Puerta-Alcalde, Carolina Garcia-Vidal, Anna Pagotto, Daniela C Gonçalves-Bradley, Paul E Verweij
Invasive candidiasis (IC) is a serious infection caused by several Candida species, and the most common fungal disease in hospitals in high-income countries. Despite overall improvements in health systems and ICU care in the last few decades, as well as the development of different antifungals and microbiological techniques, mortality rates in IC have not substantially improved. The aim of this review is to summarize the main issues underlying the management of adults affected by IC, focusing on specific forms of the infection: IC developed by ICU patients, IC observed in haematological patients, breakthrough candidaemia, sanctuary site candidiasis, intra-abdominal infections and other challenging infections...
May 23, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37211751/co-occurrence-of-multiple-plasmid-borne-linezolid-resistance-genes-optra-cfr-poxta2-and-cfr-d-in-an-enterococcus-faecalis-isolate-from-retail-meat
#26
JOURNAL ARTICLE
Weiyi Shen, Rong Zhang, Jiachang Cai
OBJECTIVES: To investigate the molecular characteristics and transferability of plasmid-borne linezolid resistance genes optrA, cfr, poxtA2 and cfr(D) genes in one linezolid-resistant Enterococcus faecalis DM86 from retail meat. METHODS: E. faecalis DM86 was screened for the presence of known linezolid resistance genes via PCR analysis. Conjugation experiments were used to evaluate the transferability of the resistance genes. The complete genome of E. faecalis DM86 was obtained using both the Illumina and Nanopore platforms...
May 20, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37210083/molecular-characterization-of-cefepime-and-aztreonam-nonsusceptibility-in-haemophilus-influenzae
#27
JOURNAL ARTICLE
Wei-Hung Cheng, Wan-Yu Shao, Man-Yu Wen, Pei-Yi Su, Cheng-Hsun Ho
BACKGROUND: Cefepime and aztreonam are highly efficacious against H. influenzae, and resistant strains are rare. In this study, we isolated cefepime- and aztreonam-nonsusceptible H. influenzae strains and addressed the molecular basis of their resistance to cefepime and aztreonam. METHODS: Two hundred and 28 specimens containing H. influenzae were screened, of which 32 isolates were enrolled and applied to antimicrobial susceptibility testing and whole-genome sequencing...
May 20, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37209424/efficacy-of-favipiravir-against-influenza-virus-resistant-to-both-baloxavir-and-neuraminidase-inhibitors
#28
JOURNAL ARTICLE
Maki Kiso, Seiya Yamayoshi, Yoshihiro Kawaoka
OBJECTIVES: Widespread resistance of influenza viruses to neuraminidase (NA) inhibitor or polymerase inhibitor, baloxavir, is a major public health concern. The amino acid mutations R152K in NA and I38T in polymerase acidic (PA) are responsible for resistance to NA inhibitors and baloxavir, respectively. METHODS: We generated recombinant A(H1N1)pdm09 viruses possessing NA-R152K, PA-I38T or both mutations by using a plasmid-based reverse genetics system, characterized their virological properties in vitro and in vivo, and examined whether oseltamivir, baloxavir and favipiravir are effective against these mutant viruses...
May 20, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37209112/performance-evaluation-of-the-umic%C3%A2-cefiderocol-to-determine-mic-in-gram-negative-bacteria
#29
JOURNAL ARTICLE
Laurent Dortet, Claudia Niccolai, Niels Pfennigwerth, Stefanie Frisch, Camille Gonzalez, Alberto Antonelli, Tommaso Giani, Robert Hoenings, Soeren Gatermann, Gian Maria Rossolini, Thierry Naas
BACKGROUND: Cefiderocol is a catechol-substituted cephalosporin with potent in vitro activity against carbapenem-resistant (CR) Gram-negative bacteria (GNB). Cefiderocol susceptibility testing is complex because iron concentrations need to be taken into consideration. Here, we assessed the clinical performance of Bruker's UMIC® Cefiderocol and corresponding iron-depleted CAMHB to determine MIC by broth microdilution (BMD) for clinically relevant GNB. METHODS: MICs of cefiderocol for 283 GN clinical isolates were determined by BMD using iron-depleted CAMHB...
May 20, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37207353/citrobacter-freundii-resistant-to-novel-%C3%AE-lactamase-inhibitor-combinations-and-cefiderocol-co-producing-class-a-b-and-d-carbapenemases-encoded-by-transferable-plasmids
#30
JOURNAL ARTICLE
Eleonora Riccobono, Sara Salvetti, Marco Coppi, Iolanda Montenora, Vincenzo Di Pilato, Gian Maria Rossolini
OBJECTIVES: To characterize a carbapenem-resistant Citrobacter freundii (Cf-Emp) co-producing class A, B and D carbapenemases, resistant to novel β-lactamase inhibitor combinations (BLICs) and cefiderocol. METHODS: Carbapenemase production was tested by an immunochromatography assay. Antibiotic susceptibility testing (AST) was performed by broth microdilution. WGS was performed using short- and long-read sequencing. Transfer of carbapenemase-encoding plasmids was assessed by conjugation experiments...
May 19, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37202829/in-vivo-pharmacodynamic-study-of-contezolid-acefosamil-a-prodrug-of-contezolid-for-oral-and-intravenous-administration
#31
JOURNAL ARTICLE
Xiu-Kun Wang, Jie Yu, Chun-Yang Xie, Xin-Xin Hu, Tong-Ying Nie, Xue Li, Peng-He Wang, Guo-Qing Li, Hong Yuan, Xin-Yi Yang, Cong-Ran Li, Xue-Fu You
OBJECTIVES: Contezolid acefosamil is a novel O-acyl phosphoramidate prodrug of contezolid. In the current study, we aimed to systemically evaluate the efficacy of contezolid acefosamil against infections caused by multiple Gram-positive pathogens, and compare the efficacy of the prodrug by oral and intravenous administrations. METHODS: The in vivo pharmacodynamic efficacy of contezolid acefosamil was evaluated in mouse models of systemic (with five S. aureus, three S...
May 18, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37192385/antimicrobial-resistance-of-neisseria-gonorrhoeae-in-latin-american-countries-a-systematic-review
#32
JOURNAL ARTICLE
María Macarena Sandoval, Ariel Bardach, Carlos Rojas-Roque, Tomás Alconada, Jorge A Gomez, Thatiana Pinto, Carolina Palermo, Agustin Ciapponi
BACKGROUND: Detailed information is needed on the dynamic pattern of antimicrobial resistance (AMR) in Neisseria gonorrhoeae in Latin America and the Caribbean (LAC). OBJECTIVES: To conduct a systematic review of AMR in N. gonorrhoeae in LAC. METHODS: Electronic searches without language restrictions were conducted in PubMed, Embase, Cochrane Library, EconLIT, Cumulative Index of Nursing and Allied Health Literature, Centre for Reviews and Dissemination, and Latin American and Caribbean Literature in Health Sciences...
May 16, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37190910/a-multicentre-retrospective-audit-of-fosfomycin-use-for-urinary-tract-infections-in-australian-children-and-adolescents
#33
JOURNAL ARTICLE
Rachael Purcell, Daniel Yeoh, Asha Bowen, Philip N Britton, Jeremy P Carr, Ming Chen, Kaman Cheung, Julia Clark, Adam Irwin, Tony Lai, Ulrik Lorenzen, Andrew Steer, Sophie Wen, Phoebe Williams, Natalie Yap, Celia Cooper, Amanda Gwee
BACKGROUND: Urinary tract infections (UTIs) due to MDR organisms are increasingly common. The lack of paediatric data on efficacious antibiotics makes UTI treatment particularly challenging. Data on the efficacy of fosfomycin use for UTI in children are variable. METHODS: We conducted a retrospective audit of children aged 0-18 years who were treated with fosfomycin for UTI at seven tertiary paediatric hospitals in Australia over a 7 year period, from 2014 to 2020...
May 16, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37170886/efficacy-and-safety-of-molnupiravir-for-the-treatment-of-sars-cov-2-infection-a-systematic-review-and-meta-analysis
#34
JOURNAL ARTICLE
Jakob J Malin, Stephanie Weibel, Henning Gruell, Nina Kreuzberger, Miriam Stegemann, Nicole Skoetz
BACKGROUND: The role of molnupiravir for coronavirus disease 2019 (COVID-19) treatment is unclear. METHODS: We conducted a systematic review until 1 November 2022 searching for randomized controlled trials (RCTs) involving COVID-19 patients comparing molnupiravir [±standard of care (SoC)] versus SoC and/or placebo. Data were pooled in random-effects meta-analyses. Certainty of evidence was assessed according to the Grading of Recommendations, Assessment, Development and Evaluations approach...
May 12, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37161664/health-system-evaluation-of-fluoroquinolone-hypersensitivity-an-assessment-of-cross-reactivity
#35
JOURNAL ARTICLE
Kathleen K Adams, Sunish Shah
No abstract text is available yet for this article.
May 10, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37161662/incidence-of-esbls-and-carbapenemases-among-enterobacterales-and-carbapenemases-in-pseudomonas-aeruginosa-isolates-collected-globally-results-from-atlas-2017-2019
#36
JOURNAL ARTICLE
Ana C Gales, Gregory Stone, Daniel F Sahm, Mark G Wise, Eric Utt
OBJECTIVES: To assess the global and regional distribution of ESBLs in Enterobacterales and carbapenemases in Enterobacterales and Pseudomonas aeruginosa. METHODS: Antimicrobial susceptibility of isolates collected from ATLAS (2017-2019) was determined per CLSI guidelines. Enterobacterales exhibiting meropenem MICs ≥2 mg/L and/or ceftazidime/avibactam and/or aztreonam/avibactam MICs ≥16 mg/L, Escherichia coli and Klebsiella pneumoniae with aztreonam and/or ceftazidime MICs ≥2 mg/L, and P...
May 10, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37161536/up-regulation-of-resident-chromosomal-fosb-gene-expression-a-novel-mechanism-of-acquired-fosfomycin-resistance-in-mrsa
#37
JOURNAL ARTICLE
Noemi Aiezza, Alberto Antonelli, Marco Coppi, Vincenzo Di Pilato, Tommaso Giani, Gian Maria Rossolini
OBJECTIVES: This study investigated fosfomycin susceptibility and mechanisms of resistance in a collection of 99 Staphylococcus aureus isolated from cases of hospital-acquired pneumonia, previously collected from a multicentre survey carried out in Italy. METHODS: Fosfomycin susceptibility was tested by reference agar dilution. Bioinformatic and gene expression analysis, mutant selection experiments and WGS were executed to characterize fosfomycin resistance mechanisms...
May 10, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37147875/transmission-of-s230r-integrase-drug-resistance-mutation-affecting-second-generation-integrase-inhibitors-in-a-french-primary-hiv-1-infected-man
#38
JOURNAL ARTICLE
Maud Salmona, Caroline Lascoux-Combe, Marie Laure Nere, Emma Rubenstein, Jean Michel Molina, Constance Delaugerre, Marie Laure Chaix
No abstract text is available yet for this article.
May 6, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37147849/-if-you-want-to-go-far-go-together-community-based-behaviour-change-interventions-to-improve-antibiotic-use-a-systematic-review-of-quantitative-and-qualitative-evidence
#39
JOURNAL ARTICLE
Ioana Ghiga, Anna Sidorchuk, Emma Pitchforth, Cecilia Stålsby Lundborg, Anna Machowska
INTRODUCTION: A large proportion of the burden of infections with antibiotic-resistant bacteria is linked to community-associated infections. This suggests that interventions set in community settings are needed. Currently there is a gap in understanding the potential of such interventions across all geographies. This systematic review aimed to synthesize the evidence on the value of community-based behaviour change interventions to improve antibiotic use. These are any interventions or innovations to services intended to stimulate behaviour changes among the public towards correct antibiotic use, delivered in a community setting and online...
May 6, 2023: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/37144593/healthcare-associated-ndm-1-producing-enterobacter-hormaechei-subsp-xiangfangensis-clone-st136-emerging-as-pathogen-of-companion-animals-in-brazil
#40
JOURNAL ARTICLE
Vanessa C Kobs, Francielle de Medeiros, Patrícia P Fernandes, Roseneide C Deglmann, Herrison Fontana, Brenda Cardoso, Elder Sano, Fernanda Esposito, Fábio P Sellera, Nilton Lincopan, Paulo H C de França
No abstract text is available yet for this article.
May 5, 2023: Journal of Antimicrobial Chemotherapy
journal
journal
20139
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.